Cardiovascular disease and impoverishment averted due to a salt reduction policy in South Africa: an extended cost-effectiveness analysis
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The South African Government recently set targets to reduce cardiovascular disease (CVD) by lowering salt consumption. We conducted an extended cost-effectiveness analysis (ECEA) to model the potential health and economic impacts of this salt policy. We used surveys and epidemiologic studies to estimate reductions in CVD resulting from lower salt intake. We calculated the average out-of-pocket (OOP) cost of CVD care, using facility fee schedules and drug prices. We estimated the reduction in OOP expenditures and government subsidies due to the policy. We estimated public and private sector costs of policy implementation. We estimated financial risk protection (FRP) from the policy as (1) cases of catastrophic health expenditure (CHE) averted or (2) cases of poverty averted. We also performed a sensitivity analysis. We found that the salt policy could reduce CVD deaths by 11%, with similar health gains across income quintiles. The policy could save households US$ 4.06 million (2012) in OOP expenditures (US$ 0.29 per capita) and save the government US$ 51.25 million in healthcare subsidies (US$ 2.52 per capita) each year. The cost to the government would be only US$ 0.01 per capita; hence, the policy would be cost saving. If the private sector food reformulation costs were passed on to consumers, food expenditures would increase by <0.2% across all income quintiles. Preventing CVD could avert 2400 cases of CHE or 2000 cases of poverty yearly. Our results were sensitive to baseline CVD mortality rates and the cost of treatment. We conclude that, in addition to health gains, population salt reduction can have positive economic impacts-substantially reducing OOP expenditures and providing FRP, particularly for the middle class. The policy could also provide large government savings on health care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Feigin, V. L., Lawes, C. M., Bennett, D. A., Barker-Collo, S. L., & Parag, V. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70025-0 · Cited by 2,855 · cited 3×
“…0.19 IHD 0.07 0.07 0.07 0.07 0.08 0.03 to 0.16 HHF 0.16 0.16 0.16 0.18 0.19 0.09 to 0.33 ESRD 0.16 0.16 0.16 0.18 0.18 0.09 to 0.33 CVD CFR Stroke (Feigin et al. 2009) 0.266 0.266 0.266 0.266 0.266 0.180 to 0.350 IHD, male (Mathers et al. 2004) 0.620 0.620 0.620 0.620 0.620 0.410 to 0.830 IHD,…”
MethodInfluentialGlobal health 2035: a world converging within a generation
Jamison, D. T., Summers, L. H., Alleyne, G., Arrow, K. J., Berkley, S., Binagwaho, A., Bustreo, F., Evans, D., Feachem, R. G. A., Frenk, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)62105-4 · Cited by 1,220 · cited 3×
“ECEA is thus intended to inform priority setting, particularly for diseases that have a socioeconomic gradient – for example, between wealthy and poor, women and men, urban and rural – or which are concentrated in marginalised ethnic groups or associated with high OOP expenditures (Jamison et al. 2013).”
BackgroundSelf-citationHealth in South Africa: changes and challenges since 2009
Mayosi, B. M., Lawn, J. E., van Niekerk, A., Bradshaw, D., Abdool Karim, S. S., & Coovadia, H. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61814-5 · Cited by 555
Verguet, S., Gauvreau, C. L., Mishra, S., MacLennan, M., Murphy, S. M., Brouwer, E. D., Nugent, R. A., Zhao, K., Jha, P., & Jamison, D. T. (2015) · The Lancet Global Health · doi:10.1016/s2214-109x(15)70095-1 · Cited by 142 · cited 2×
“Recently, an analytic approach called ‘extended costeffectiveness analysis’ (ECEA) was developed to assess the broader health system impacts of public policies (Verguet et al. 2015; 2015a,b).”
BackgroundMethodSelf-citationMason, H., Shoaibi, A., Ghandour, R., O'Flaherty, M., Capewell, S., Khatib, R., Jabr, S., Unal, B., Sözmen, K., Arfa, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084445 · Cited by 110 · cited 6×
“Using population estimates (UN 2014) and total public sector costs reported for Turkey, Syria and Tunisia (Mason et al. 2014), we calculated an average per capita regulatory cost, which we multiplied by South Africa’s population size.”
BackgroundMethodInfluential
Cited by
Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
Verguet, S., Kim, J. J., & Jamison, D. T. (2016) · PharmacoEconomics · doi:10.1007/s40273-016-0414-z · Cited by 251
Self-citationSantos, J. A., Trieu, K., Raj, T. S., Arcand, J., Johnson, C., Webster, J., & McLean, R. (2017) · The Journal of Clinical Hypertension · doi:10.1111/jch.12971 · Cited by 19
Gibbs, N., Angus, C., Dixon, S., Parry, C. D., Meier, P. S., Boachie, M. K., & Verguet, S. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2021-007824 · Cited by 12
Self-citation
Metadata
- Authors
- Watkins, D. A., Olson, Z. D., Verguet, S., Nugent, R. A., & Jamison, D. T.
- Venue
- Health Policy and Planning
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-03
- Volume
- 31
- Issue
- 1
- Pages
- 75-82
- ISSN
- 0268-1080 (ISSN-L)
- 1460-2237
- OpenAlex
- W2129472020
- Cited by
- 54
- References
- 5
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiovascular disease and impoverishment averted due to a salt reduction policy in South Africa: an extended cost-effectiveness analysis. https://app.cochat.ai/papers/10.1093/heapol/czv023
- The paper
- Watkins, D. A., Olson, Z. D., Verguet, S., Nugent, R. A., & Jamison, D. T. (2016). Cardiovascular disease and impoverishment averted due to a salt reduction policy in South Africa: an extended cost-effectiveness analysis. Health Policy and Planning. https://doi.org/10.1093/heapol/czv023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.